Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Regulus Therapeutics Inc. (RGLS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
18 Jan 2024
CALSADA CRISPINA
Chief Financial Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
5,782
-48%
5,468
$1.19
$6,510.20
SELL
18 Jan 2024
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
10,056
-35%
5,468
$1.19
$6,510.20
SELL
18 Jan 2024
Hagan Joseph P
Chief Executive Officer, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
57,112
-20%
14,580
$1.19
$17,358.95
BUY
1 Mar 2022
Drygin Denis
Chief Scientific Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
100,000
+8%
7,668.6
$2.30
$17,637.78
BUY
4 Feb 2022
Drygin Denis
Chief Scientific Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
23,314
+11%
2,331.4
$2.30
$5,362.22
BUY
12 Jan 2022
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
417,006
+2%
10,000
$2.15
$21,520.00
SELL
17 May 2021
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
316,292
-0%
418.6
$8.90
$3,725.54
SELL
17 May 2021
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
41,754
-0%
86
$8.90
$765.40
SELL
16 Feb 2021
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
42,614
-0%
82.8
$17.20
$1,424.16
SELL
16 Feb 2021
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
485,756
-0%
414.4
$17.20
$7,127.68
BUY
4 Dec 2020
Sonsini Peter W.
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Growth Equity Opportunities V, LLC
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Chang Carmen
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Walker Paul Edward
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
SANDELL SCOTT D
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
MAKOWER JOSHUA
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Makhzoumi Mohamad
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Florence Anthony A. Jr.
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
Behbahani Ali
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
BUY
4 Dec 2020
BASKETT FOREST
10% Owner
Regulus Therapeutics Inc.
(RGLS)
6,451,056
+7%
439,860.22
$6.22
$2,735,930.20
SELL
16 Nov 2020
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
25,762
-0%
87.6
$5.21
$456.48
SELL
16 Nov 2020
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
215,994
-0%
609.4
$5.21
$3,175.58
SELL
14 Aug 2020
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
222,088
-0%
424.5
$6.05
$2,567.80
SELL
14 Aug 2020
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
26,638
-0%
87.2
$6.05
$527.56
SELL
15 May 2020
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
226,333
-0%
442.6
$6.27
$2,773.77
SELL
15 May 2020
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
27,510
-0%
90.9
$6.27
$569.76
SELL
18 Feb 2020
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
230,759
-0%
432.4
$8.30
$3,590.65
SELL
18 Feb 2020
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
28,419
-0%
88.8
$8.31
$737.48
SELL
2 Jan 2020
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
235,083
-0%
834.5
$9.67
$8,067.11
SELL
2 Jan 2020
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
29,307
-0%
223.9
$9.67
$2,164.44
SELL
14 Nov 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
31,546
-0%
83.3
$6.40
$533.12
SELL
14 Nov 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
243,428
-0%
583.8
$6.40
$3,736.32
SELL
1 Oct 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
32,379
-0%
234.6
$6.83
$1,601.61
SELL
1 Oct 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
249,266
-0%
874.3
$6.83
$5,968.85
SELL
15 Aug 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
258,009
-0%
437.5
$5.51
$2,408.88
SELL
15 Aug 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
34,725
-0%
89.9
$5.51
$494.99
SELL
1 Jul 2019
Chevallard Daniel R.
Chief Financial Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
77,870
-0%
266.9
$13.12
$3,500.39
SELL
1 Jul 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
262,384
-0%
578.3
$13.12
$7,584.40
SELL
1 Jul 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
35,624
-0%
222.5
$13.12
$2,918.09
SELL
14 May 2019
Chevallard Daniel R.
Chief Financial Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
80,539
-1%
1,000
$14.09
$14,089.00
SELL
14 May 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
268,167
-1%
3,935.2
$12.19
$47,966.15
SELL
14 May 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
59,309
-1%
695
$14.10
$9,796.03
BUY
7 May 2019
Sonsini Peter W.
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Growth Equity Opportunities V, LLC
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
1,189,872
+3%
37,037
$10.80
$399,999.62
BUY
7 May 2019
BARRIS PETER J
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Chang Carmen
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
MOTT DAVID M
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Walker Paul Edward
Director
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
SANDELL SCOTT D
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
MAKOWER JOSHUA
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Makhzoumi Mohamad
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Florence Anthony A. Jr.
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Behbahani Ali
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
BASKETT FOREST
10% Owner
Regulus Therapeutics Inc.
(RGLS)
2,052,454
+5%
113,670.4
$10.80
$1,227,640.40
BUY
7 May 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
64,542
+5%
3,319.4
$10.80
$35,849.52
BUY
7 May 2019
Witz Pascale
Director
Regulus Therapeutics Inc.
(RGLS)
37,849
+8%
2,963
$10.80
$32,000.40
BUY
7 May 2019
RASTETTER WILLIAM H
Director
Regulus Therapeutics Inc.
(RGLS)
154,223
+6%
9,288.9
$10.80
$100,320.13
SELL
1 Apr 2019
Chevallard Daniel R.
Chief Financial Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
9,372
-3%
325.3
$9.81
$3,192.49
SELL
1 Apr 2019
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
31,348
-1%
584.2
$9.81
$5,731.00
SELL
1 Apr 2019
Aker Christopher Ray
Sr. VP & General Counsel, Officer
Regulus Therapeutics Inc.
(RGLS)
6,287
-4%
271
$9.81
$2,659.05
BUY
28 Dec 2018
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
835,073
+0%
5,000
$10.91
$54,570.00
BUY
26 Dec 2018
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
785,073
+1%
11,640.101
$9.74
$113,337.68
BUY
16 Nov 2018
Collier Kathryn J
Director
Regulus Therapeutics Inc.
(RGLS)
27,596
+2%
710
$14.10
$10,011.00
BUY
15 Nov 2018
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
668,672
+8%
50,000
$13.61
$680,550.00
BUY
25 Jul 2017
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
1,770,677
+0%
8,333.334
$109.20
$910,000.00
BUY
25 Jul 2017
Chevallard Daniel R.
Chief Financial Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
59,415
+0%
457.875
$109.20
$49,999.95
BUY
25 Jul 2017
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
274,725
+0%
2,289.375
$109.20
$249,999.75
BUY
25 Jul 2017
RASTETTER WILLIAM H
Director
Regulus Therapeutics Inc.
(RGLS)
624,625
+0%
2,289.375
$109.20
$249,999.75
BUY
25 Jul 2017
Hagan Joseph P
President and CEO, Director, Officer
Regulus Therapeutics Inc.
(RGLS)
241,297
+0%
1,831.5
$109.20
$199,999.81
BUY
21 Mar 2017
PAPADOPOULOS STELIOS
Director
Regulus Therapeutics Inc.
(RGLS)
700,677
+0%
4,166.667
$145.90
$607,900.00
BUY
7 Mar 2017
RASTETTER WILLIAM H
Director
Regulus Therapeutics Inc.
(RGLS)
350,000
+0%
2,083.334
$138.00
$287,500.00
BUY
3 Mar 2016
Hagan Joseph P
Chief Operating Officer, Officer
Regulus Therapeutics Inc.
(RGLS)
10,000
+0%
83.333
$862.80
$71,900.00
SELL
23 Feb 2016
ALNYLAM PHARMACEUTICALS, INC.
10% Owner
Regulus Therapeutics Inc.
(RGLS)
4,896,716
-0%
8,333.334
$861.60
$7,180,000.00
Home